BC Innovations | May 5, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-22 (miR-22)

Cancer INDICATION: Acute myelogenous leukemia (AML) Mouse studies suggest miR-22 could help treat AML. In AML patient samples, miR-22 levels were higher in AML bone marrow cells than in normal hematopoietic stem cells. In a...
BC Innovations | Nov 12, 2015
Distillery Therapeutics

Therapeutics: MicroRNA-22 (miR-22)

Pulmonary disease Patient sample and mouse studies suggest inhibiting miR-22 could help treat emphysema. Levels of miR-22 were higher in lung dendritic cells from patients with emphysema than from healthy controls. In mice exposed to...
Items per page:
1 - 2 of 2